The Second Affiliated Hospital, Shantou University Medical College
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Zhiyang
NCT05904964: Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)

Recruiting
3
288
RoW
Disitamab vedotin, RC48, Endocrine therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
HR Positive/HER2 Low Expression Metastatic Breast Cancer
03/28
03/30
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Zhiyang
NCT05904964: Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)

Recruiting
3
288
RoW
Disitamab vedotin, RC48, Endocrine therapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
HR Positive/HER2 Low Expression Metastatic Breast Cancer
03/28
03/30

Download Options